The round was led by Proofpoint Capital, a U.S.-based venture firm formed by seasoned healthcare operators, with participation from new investors Osage Venture Partners and NewHealth Ventures. Continued strong support and investment came from existing investors, including aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures, and Viola Ventures..

本轮融资由美国风险投资公司Proofpoint Capital领投，该公司由资深医疗运营商组建，新投资者Osage Venture Partners和NewHealth Ventures也参与其中。现有投资者继续提供强有力的支持和投资，其中包括aMoon、梅奥诊所、Saban Ventures、Shoni Health Ventures和Viola Ventures。

Lin Health tackles the biggest blind spot in U.S. healthcare: chronic pain, which costs more than cancer and diabetes combined at $635 billion annually. Our evidence-based, award-winning treatment retrains maladaptive pain circuits and restores function, bridging medical and behavioral care through elements of Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, Cognitive Behavioral Therapy, and other neuroplastic pain recovery techniques.

林健康解决了美国医疗保健中最大的盲点：慢性疼痛，其每年花费高达6350亿美元，超过癌症和糖尿病的总和。我们基于证据、屡获殊荣的治疗方法通过疼痛重构疗法、情绪觉察与表达疗法、认知行为疗法以及其他神经可塑性疼痛恢复技术，重新训练适应不良的疼痛回路并恢复功能，弥合医学与行为护理之间的鸿沟。

Our adjunctive care improves population health, reduces provider burnout, supports value-based outcomes, lowers the total cost of care, and prevents system leakage. Founded in 2021 by industry veterans and backed by leading investment firms, we partner with health systems, clinics, and payers to deliver immediately accessible continuity of care, built on end-to-end proprietary software that handles the entire business side of care delivery.

我们的辅助护理改善了人口健康，减轻了医疗提供者的倦怠，支持基于价值的结果，降低了护理的总成本，并防止了系统漏损。公司成立于2021年，由行业资深人士创立，并得到领先投资机构的支持，我们与卫生系统、诊所和支付方合作，提供即时可及的连续护理，依托端到端的专有软件，处理护理交付的整个业务方面。

With nationwide payer coverage for 60 million Americans, Lin is on a mission to reclaim lives from chronic pain..

林致力于从慢性疼痛中挽救生命，全美有6000万人的支付者覆盖。